Larvol Delta - Targeting-both-BET-and-CBPEP300-proteins-with-the-novel-dual-inhibitors-NEO2734-and-NEO1132-leads-to-antitumor-activity-in-Multiple-Myeloma

NEO1132 - Epigenetix, EPIGeNE

NEO2734 - EPIGeNE, Epigenetix

birabresib (OTX015) - Merck (MSD)

I-BET151 - GSK

JQ-1 - Roche

molibresib (GSK525762) - GSK

http://www.ncbi.nlm.nih.gov/pubmed/32997383

Oct 1, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next